{"product_id":"diagnostic-pathology-soft-tissue-tumors-hardback-9780323661102","title":"Diagnostic Pathology: Soft Tissue Tumors (Hardback) 9780323661102","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Pathology: Soft Tissue Tumors\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eStay up to date with recent changes in soft tissue pathology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMatthew R. Lindberg (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323661102, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 25 June 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e920 pages, \u003cp\u003eApprox. 2000 full-color illustrations\u003c\/p\u003e\n\u003cbr\u003e27.9 x 21.6 x 4.4 cm, 2.65 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eCovering all aspects of soft tissue pathology, this highly regarded volume in the \u003ci\u003eDiagnostic Pathology\u003c\/i\u003e series is an\u003cb\u003e excellent point-of-care resource for pathologists at all levels of experience and training\u003c\/b\u003e—both as a quick reference and as an efficient review to improve knowledge and skills. Specifically designed as a point-of-care resource, the updated third edition uses a templated, highly formatted design; concise, bulleted text; and superior color images throughout that demonstrate the variety of differentiating factors in soft tissue tumors.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eIncludes \u003cb\u003enew chapters\u003c\/b\u003e on recently described entities such as superficial CD34-positive fibroblastic tumor and atypical spindle cell lipomatous tumor, with numerous images detailing characteristic histology for ease of recognition\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers \u003cb\u003erecent advances and discoveries in immunohistochemistry and molecular pathology\u003c\/b\u003e of soft tissue tumors, including new IHC antibodies FOSB and H3k27me3, ALK-1 expression in angiomatoid fibrous histiocytoma, and entries on BCOR-CCNB2 fusion-defined sarcoma, novel PDGFD rearrangements in dermatofibrosarcoma protuberans, and RB gene loss in acral fibromyxoma\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003eextensive new 8th edition AJCC staging information\u003c\/b\u003e for soft tissue sarcomas in convenient table format\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003emore than 2,000 annotated images throughout\u003c\/b\u003e, including gross pathology, a wide range of stains, and detailed medical illustrations, with coverage of key diagnostic features for each tumor as well as morphologic variants\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003eeasy-to-reference chapters\u003c\/b\u003e that begin with Key Facts, followed by terminology, clinical issues, macro- and microscopic features, ancillary tests and a list of differential diagnoses with bulleted characteristics\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003ean organized framework\u003c\/b\u003e that includes \"Approach to Diagnosis\" chapters designed to help you successfully recognize and diagnose challenging soft tissue tumors with the availability of common patterns and histologic features\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eEnhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eSoft Tissue Introduction\u003c\/p\u003e \u003cp\u003eIntroduction and Overview\u003c\/p\u003e \u003cp\u003eGross Examination\u003c\/p\u003e \u003cp\u003eGrading and Staging\u003c\/p\u003e \u003cp\u003eAncillary Techniques\u003c\/p\u003e \u003cp\u003eSoft Tissue Immunohistochemistry\u003c\/p\u003e \u003cp\u003eMolecular Features of Soft Tissue Tumors\u003c\/p\u003e \u003cp\u003eDiagnostic Approach to Soft Tissue Tumors\u003c\/p\u003e \u003cp\u003eOverview\u003c\/p\u003e \u003cp\u003eBiopsy and Resection of Soft Tissue Tumors\u003c\/p\u003e \u003cp\u003eClinical Approach\u003c\/p\u003e \u003cp\u003eAge- and Location-Based Approach to Diagnosis\u003c\/p\u003e \u003cp\u003eHistologic Approach\u003c\/p\u003e \u003cp\u003ePattern-Based Approach to Diagnosis\u003c\/p\u003e \u003cp\u003eFeature-Based Approach to Diagnosis\u003c\/p\u003e \u003cp\u003eTumors of Adipose Tissue\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eLipoma\u003c\/p\u003e \u003cp\u003eLipomatosis of Nerve\u003c\/p\u003e \u003cp\u003eSynovial Lipomatosis\u003c\/p\u003e \u003cp\u003eAngiolipoma\u003c\/p\u003e \u003cp\u003eSpindle Cell\/Pleomorphic Lipoma\u003c\/p\u003e \u003cp\u003eChondroid Lipoma\u003c\/p\u003e \u003cp\u003eMyolipoma\u003c\/p\u003e \u003cp\u003eHibernoma\u003c\/p\u003e \u003cp\u003eMyelolipoma\u003c\/p\u003e \u003cp\u003eLipoblastoma\u003c\/p\u003e \u003cp\u003eIntermediate, Locally Aggressive\u003c\/p\u003e \u003cp\u003eAtypical Lipomatous Tumor\/Well-Differentiated Liposarcoma\u003c\/p\u003e \u003cp\u003eAtypical Spindle Cell Lipomatous Tumor\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eDedifferentiated Liposarcoma\u003c\/p\u003e \u003cp\u003eMyxoid Liposarcoma\u003c\/p\u003e \u003cp\u003ePleomorphic Liposarcoma\u003c\/p\u003e \u003cp\u003eFibroblastic\/Myofibroblastic Lesions\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eNodular Fasciitis\u003c\/p\u003e \u003cp\u003eProliferative Fasciitis\/Myositis\u003c\/p\u003e \u003cp\u003eIschemic Fasciitis\u003c\/p\u003e \u003cp\u003eMyositis Ossificans\u003c\/p\u003e \u003cp\u003eFibroosseous Pseudotumor of the Digit\u003c\/p\u003e \u003cp\u003eFibroma of Tendon Sheath\u003c\/p\u003e \u003cp\u003eDesmoplastic Fibroblastoma\u003c\/p\u003e \u003cp\u003eElastofibroma\u003c\/p\u003e \u003cp\u003eAngiofibroma of Soft Tissue\u003c\/p\u003e \u003cp\u003eMammary-Type Myofibroblastoma\u003c\/p\u003e \u003cp\u003eIntranodal Palisaded Myofibroblastoma\u003c\/p\u003e \u003cp\u003eSuperficial CD34(+) Fibroblastic Tumor\u003c\/p\u003e \u003cp\u003ePleomorphic Fibroma\u003c\/p\u003e \u003cp\u003eDermatomyofibroma\u003c\/p\u003e \u003cp\u003eStoriform Collagenoma\u003c\/p\u003e \u003cp\u003eKeloid\u003c\/p\u003e \u003cp\u003eNuchal-Type Fibroma\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003ePalmar\/Plantar Fibromatosis\u003c\/p\u003e \u003cp\u003eDesmoid-Type Fibromatosis\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003eDermatofibrosarcoma Protuberans\u003c\/p\u003e \u003cp\u003eSolitary Fibrous Tumor\u003c\/p\u003e \u003cp\u003eLow-Grade Myofibroblastic Sarcoma\u003c\/p\u003e \u003cp\u003eInflammatory Myofibroblastic Tumor\u003c\/p\u003e \u003cp\u003eMyxoinflammatory Fibroblastic Sarcoma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eAdult-Type Fibrosarcoma\u003c\/p\u003e \u003cp\u003eMyxofibrosarcoma\u003c\/p\u003e \u003cp\u003eLow-Grade Fibromyxoid Sarcoma\u003c\/p\u003e \u003cp\u003eSclerosing Epithelioid Fibrosarcoma\u003c\/p\u003e \u003cp\u003ePediatric Fibroblastic\/Myofibroblastic Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eFibrous Hamartoma of Infancy\u003c\/p\u003e \u003cp\u003eCalcifying Aponeurotic Fibroma\u003c\/p\u003e \u003cp\u003eCalcifying Fibrous Tumor\u003c\/p\u003e \u003cp\u003eInclusion Body Fibromatosis\u003c\/p\u003e \u003cp\u003eHyaline Fibromatosis Syndrome\u003c\/p\u003e \u003cp\u003eFibromatosis Colli\u003c\/p\u003e \u003cp\u003eGardner Fibroma\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003eLipofibromatosis\u003c\/p\u003e \u003cp\u003eGiant Cell Fibroblastoma\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003eInfantile Fibrosarcoma\u003c\/p\u003e \u003cp\u003eFibrohistiocytic, Histiocytic, and Dendritic Cell Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eDermatofibroma and Fibrous Histiocytoma\u003c\/p\u003e \u003cp\u003eDeep Benign Fibrous Histiocytoma\u003c\/p\u003e \u003cp\u003eLocalized-Type Tenosynovial Giant Cell Tumor\u003c\/p\u003e \u003cp\u003eDiffuse-Type Tenosynovial Giant Cell Tumor\u003c\/p\u003e \u003cp\u003eCellular Neurothekeoma\u003c\/p\u003e \u003cp\u003eXanthomas\u003c\/p\u003e \u003cp\u003eSolitary (Juvenile) Xanthogranuloma\u003c\/p\u003e \u003cp\u003eReticulohistiocytoma\u003c\/p\u003e \u003cp\u003eDeep Granuloma Annulare\u003c\/p\u003e \u003cp\u003eRheumatoid Nodule\u003c\/p\u003e \u003cp\u003eLangerhans Cell Histiocytosis\u003c\/p\u003e \u003cp\u003eExtranodal Rosai-Dorfman Disease\u003c\/p\u003e \u003cp\u003eCrystal-Storing Histiocytosis\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003ePlexiform Fibrohistiocytic Tumor\u003c\/p\u003e \u003cp\u003eGiant Cell Tumor of Soft Tissue\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eHistiocytic Sarcoma\u003c\/p\u003e \u003cp\u003eFollicular Dendritic Cell Sarcoma\u003c\/p\u003e \u003cp\u003eInterdigitating Dendritic Cell Sarcoma\u003c\/p\u003e \u003cp\u003eSmooth Muscle Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eSmooth Muscle Hamartoma\u003c\/p\u003e \u003cp\u003eSuperficial Leiomyoma\u003c\/p\u003e \u003cp\u003eDeep Leiomyoma\u003c\/p\u003e \u003cp\u003eIntermediate\u003c\/p\u003e \u003cp\u003eEpstein-Barr Virus-Associated Smooth Muscle Tumor\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eLeiomyosarcoma\u003c\/p\u003e \u003cp\u003ePericytic (Perivascular) Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eGlomus Tumors (and Variants)\u003c\/p\u003e \u003cp\u003eMyopericytoma\u003c\/p\u003e \u003cp\u003eMyofibroma and Myofibromatosis\u003c\/p\u003e \u003cp\u003eAngioleiomyoma\u003c\/p\u003e \u003cp\u003eTumors of Skeletal Muscle\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eFocal Myositis\u003c\/p\u003e \u003cp\u003eAdult Rhabdomyoma\u003c\/p\u003e \u003cp\u003eFetal Rhabdomyoma\u003c\/p\u003e \u003cp\u003eGenital Rhabdomyoma\u003c\/p\u003e \u003cp\u003eCardiac Rhabdomyoma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eEmbryonal Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eAlveolar Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eSpindle Cell Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eSclerosing Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003ePleomorphic Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eEpithelioid Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eVascular Tumors (Including Lymphatics)\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003ePapillary Endothelial Hyperplasia\u003c\/p\u003e \u003cp\u003eBacillary Angiomatosis\u003c\/p\u003e \u003cp\u003eCongenital Hemangioma\u003c\/p\u003e \u003cp\u003eInfantile Hemangioma\u003c\/p\u003e \u003cp\u003eLobular Capillary Hemangioma\u003c\/p\u003e \u003cp\u003eEpithelioid Hemangioma\u003c\/p\u003e \u003cp\u003eSpindle Cell Hemangioma\u003c\/p\u003e \u003cp\u003eIntramuscular Hemangioma\u003c\/p\u003e \u003cp\u003eHobnail Hemangioma\u003c\/p\u003e \u003cp\u003eAcquired Tufted Angioma\u003c\/p\u003e \u003cp\u003eMicrovenular Hemangioma\u003c\/p\u003e \u003cp\u003eSinusoidal Hemangioma\u003c\/p\u003e \u003cp\u003eGlomeruloid Hemangioma\u003c\/p\u003e \u003cp\u003eAngiomatosis\u003c\/p\u003e \u003cp\u003eLymphangioma\u003c\/p\u003e \u003cp\u003eMassive Localized Lymphedema\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003eKaposiform Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003ePapillary Intralymphatic Angioendothelioma\u003c\/p\u003e \u003cp\u003eRetiform Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eComposite Hemangioendothelioma\u003c\/p\u003e \u003cp\u003ePseudomyogenic Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eAtypical Vascular Lesion\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eEpithelioid Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eAngiosarcoma\u003c\/p\u003e \u003cp\u003eKaposi Sarcoma\u003c\/p\u003e \u003cp\u003eChondro-Osseous Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eSoft Tissue Chondroma\u003c\/p\u003e \u003cp\u003eSynovial Chondromatosis\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eExtraskeletal Osteosarcoma\u003c\/p\u003e \u003cp\u003eExtraskeletal Mesenchymal Chondrosarcoma\u003c\/p\u003e \u003cp\u003ePeripheral Nerve Sheath Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eSolitary Circumscribed Neuroma\u003c\/p\u003e \u003cp\u003eSchwannoma\u003c\/p\u003e \u003cp\u003eNeurofibroma\u003c\/p\u003e \u003cp\u003ePerineurioma\u003c\/p\u003e \u003cp\u003eHybrid Nerve Sheath Tumor\u003c\/p\u003e \u003cp\u003eGranular Cell Tumor\u003c\/p\u003e \u003cp\u003eDermal Nerve Sheath Myxoma\u003c\/p\u003e \u003cp\u003eGanglioneuroma\u003c\/p\u003e \u003cp\u003eNeuromuscular Choristoma\u003c\/p\u003e \u003cp\u003eIntermediate\u003c\/p\u003e \u003cp\u003eMelanotic Schwannoma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eMalignant Peripheral Nerve Sheath Tumor\u003c\/p\u003e \u003cp\u003eEpithelioid Malignant Peripheral Nerve Sheath Tumor\u003c\/p\u003e \u003cp\u003eEctomesenchymoma\u003c\/p\u003e \u003cp\u003eGenital Stromal Tumors\u003c\/p\u003e \u003cp\u003eFibroepithelial Stromal Polyp\u003c\/p\u003e \u003cp\u003eAngiomyofibroblastoma\u003c\/p\u003e \u003cp\u003eCellular Angiofibroma\u003c\/p\u003e \u003cp\u003eDeep (Aggressive) Angiomyxoma\u003c\/p\u003e \u003cp\u003eTumors of Mesothelial Cells\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eAdenomatoid Tumor\u003c\/p\u003e \u003cp\u003eMulticystic Peritoneal Mesothelioma\u003c\/p\u003e \u003cp\u003eWell-Differentiated Papillary Mesothelioma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eMalignant Mesothelioma\u003c\/p\u003e \u003cp\u003eHematopoietic Tumors in Soft Tissue\u003c\/p\u003e \u003cp\u003eSolitary Extramedullary Plasmacytoma\u003c\/p\u003e \u003cp\u003eMyeloid Sarcoma\u003c\/p\u003e \u003cp\u003eLymphoma of Soft Tissue\u003c\/p\u003e \u003cp\u003eTumors of Uncertain Differentiation\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eIntramuscular Myxoma\u003c\/p\u003e \u003cp\u003eJuxtaarticular Myxoma\u003c\/p\u003e \u003cp\u003eSuperficial Angiomyxoma\u003c\/p\u003e \u003cp\u003eAcral Fibromyxoma\u003c\/p\u003e \u003cp\u003ePleomorphic Hyalinizing Angiectatic Tumor\u003c\/p\u003e \u003cp\u003eAneurysmal Bone Cyst of Soft Tissue\u003c\/p\u003e \u003cp\u003eEctopic Hamartomatous Thymoma\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003eHemosiderotic Fibrolipomatous Tumor\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003eAtypical Fibroxanthoma\u003c\/p\u003e \u003cp\u003eAngiomatoid Fibrous Histiocytoma\u003c\/p\u003e \u003cp\u003eOssifying Fibromyxoid Tumor\u003c\/p\u003e \u003cp\u003eMyoepithelioma of Soft Tissue\u003c\/p\u003e \u003cp\u003ePhosphaturic Mesenchymal Tumor\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eSynovial Sarcoma\u003c\/p\u003e \u003cp\u003eEpithelioid Sarcoma\u003c\/p\u003e \u003cp\u003eAlveolar Soft Part Sarcoma\u003c\/p\u003e \u003cp\u003eClear Cell Sarcoma\u003c\/p\u003e \u003cp\u003ePerivascular Epithelioid Cell Tumor (PEComa)\u003c\/p\u003e \u003cp\u003eDesmoplastic Small Round Cell Tumor\u003c\/p\u003e \u003cp\u003eExtraskeletal Ewing Sarcoma\u003c\/p\u003e \u003cp\u003eExtraskeletal Myxoid Chondrosarcoma\u003c\/p\u003e \u003cp\u003eExtrarenal Rhabdoid Tumor\u003c\/p\u003e \u003cp\u003eIntimal Sarcoma\u003c\/p\u003e \u003cp\u003eUndifferentiated\/Unclassified Sarcomas\u003c\/p\u003e \u003cp\u003eUndifferentiated Pleomorphic Sarcoma\u003c\/p\u003e \u003cp\u003eUndifferentiated Round Cell Sarcoma With *CIC-DUX4* Translocation\u003c\/p\u003e \u003cp\u003eBCOR-CCNB3 (Ewing-Like) Sarcoma\u003c\/p\u003e \u003cp\u003eMesenchymal Tumors of the Gastrointestinal Tract\u003c\/p\u003e \u003cp\u003eBenign Neural Gastrointestinal Polyps\u003c\/p\u003e \u003cp\u003eGastrointestinal Stromal Tumor\u003c\/p\u003e \u003cp\u003eGastrointestinal Schwannoma\u003c\/p\u003e \u003cp\u003eGastrointestinal Smooth Muscle Neoplasms\u003c\/p\u003e \u003cp\u003eInflammatory Fibroid Polyp\u003c\/p\u003e \u003cp\u003eGangliocytic Paraganglioma\u003c\/p\u003e \u003cp\u003ePlexiform Fibromyxoma\u003c\/p\u003e \u003cp\u003eMalignant Gastrointestinal Neuroectodermal Tumor\u003c\/p\u003e \u003cp\u003eOther Entities\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eAmyloidoma\u003c\/p\u003e \u003cp\u003eGanglion Cyst\u003c\/p\u003e \u003cp\u003eTumoral Calcinosis\u003c\/p\u003e \u003cp\u003eIdiopathic Tumefactive Fibroinflammatory Lesions\u003c\/p\u003e \u003cp\u003eCardiac Myxoma\u003c\/p\u003e \u003cp\u003eCardiac Fibroma\u003c\/p\u003e \u003cp\u003eCongenital Granular Cell Epulis\u003c\/p\u003e \u003cp\u003eNasopharyngeal Angiofibroma\u003c\/p\u003e \u003cp\u003eSinonasal Glomangiopericytoma\u003c\/p\u003e \u003cp\u003eEctopic Meningioma\u003c\/p\u003e \u003cp\u003eGlial Heterotopia\u003c\/p\u003e \u003cp\u003eIntermediate\u003c\/p\u003e \u003cp\u003eParaganglioma\u003c\/p\u003e \u003cp\u003ePeripheral Hemangioblastoma\u003c\/p\u003e \u003cp\u003eMelanotic Neuroectodermal Tumor of Infancy\u003c\/p\u003e \u003cp\u003eEpendymoma of Soft Tissue\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eMetastatic Tumors to Soft Tissue Sites\u003c\/p\u003e \u003cp\u003eNeuroblastoma and Ganglioneuroblastoma\u003c\/p\u003e \u003cp\u003eExtraaxial Soft Tissue Chordoma\u003c\/p\u003e \u003cp\u003eUndifferentiated Embryonal Sarcoma of the Liver\u003c\/p\u003e \u003cp\u003ePrimary Pulmonary Myxoid Sarcoma\u003c\/p\u003e \u003cp\u003eBiphenotypic Sinonasal Sarcoma\u003c\/p\u003e \u003cp\u003eSpindle Epithelial Tumor With Thymus-Like Differentiation\u003c\/p\u003e \u003cp\u003eLow-Grade Endometrial Stromal Sarcoma\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648356143384,"sku":"9780323661102","price":187.49,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323661102_b5153fbb-d205-48cd-b164-5ae070604312.jpg?v=1694990072","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/diagnostic-pathology-soft-tissue-tumors-hardback-9780323661102","provider":"Freshly Printed Books","version":"1.0","type":"link"}